Helsinn Healthcare S.A. et al. v. Hospira Inc.
terminated- Docket:
- 1:15-cv-00264
- Filed:
- 2015-03-25
- Terminated:
- 2018-09-11
Delaware Hatch-Waxman ANDA action asserting the '424 patent against Hospira Inc.; terminated in 2018.
Plaintiff
5 cases as plaintiff.
Watchlist
Email-only, free, anonymous. We'll notify you when Roche Palo Alto LLC files another patent-infringement lawsuit. One-click unsubscribe from any alert.
Delaware Hatch-Waxman ANDA action asserting the '424 patent against Hospira Inc.; terminated in 2018.
Delaware Hatch-Waxman ANDA action asserting the '424 patent against Mylan Institutional LLC (per '094 docket); terminated in 2015.
Delaware Hatch-Waxman ANDA action asserting the '424 patent; defendant not retrieved; terminated in 2015.
Delaware Hatch-Waxman ANDA action asserting the '424 patent against Cipla Ltd.; terminated in 2015.
Consolidated Hatch-Waxman ANDA action in D.N.J. (lead case 3:11-cv-03962, consolidated with 3:11-cv-05579 and 3:13-cv-05815) asserting the '724, '725, '424, and '219 patents. District court found claims valid and infringed, but the Federal Circuit reversed under the on-sale bar and the Supreme Court affirmed invalidity.